- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Relapsed and Refractory Multiple Myeloma in United States
Total 29544 results
-
National Cancer Institute (NCI)CompletedStage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Cristiana Costa Chase, DONot yet recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Alliance Foundation Trials, LLC.Pharmacyclics LLC.Active, not recruitingMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapse Multiple MyelomaUnited States
-
CelgeneCelgene CorporationCompletedMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States, Australia
-
Cogent Biosciences, Inc.Seagen Inc.TerminatedMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States
-
Millennium Pharmaceuticals, Inc.CompletedWaldenstrom Macroglobulinemia | Refractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterExelixisCompletedRelapsed or Refractory Multiple MyelomaUnited States
-
Caribou Biosciences, Inc.Enrolling by invitationLymphoma | Lymphoma, Non-Hodgkin | B Cell Lymphoma | Non-Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Hematologic Malignancy | Relapsed/Refractory Multiple Myeloma | Relapsed/Refractory Acute Myeloid Leukemia | Relapsed Non-Hodgkin Lymphoma | B-Cell Non-Hodgkin's LymphomaUnited States
-
University of PennsylvaniaGenentech, Inc.Recruiting
-
University of Maryland, BaltimoreActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Rapa Therapeutics LLCMedical College of WisconsinRecruitingRelapsed, Refractory Multiple MyelomaUnited States
-
TakedaCompletedRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States, Canada
-
University of California, San DiegoTakeda; Celgene; Janssen, LPActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedStage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
The Cleveland ClinicWithdrawnStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Plasma Cell NeoplasmUnited States
-
Adriana RossiNot yet recruitingRelapsed and/or Refractory Multiple MyelomaUnited States
-
Beth Israel Deaconess Medical CenterGenzyme, a Sanofi CompanyCompletedAcute Myeloid Leukemia | Myelodysplastic Syndrome | Acute Lymphocytic Leukemia | Hodgkins Disease | Relapsed/Refractory Chronic Lymphocytic Leukemia | Relapsed Refractory Multiple Myeloma | Relapsed/Refractory Non Hodgkin's LymphomaUnited States
-
Massachusetts General HospitalSanofi; GlaxoSmithKlineNot yet recruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapsed CancerUnited States
-
NYU Langone HealthCelgene CorporationTerminatedRelapsed or Refractory Multiple MyelomaUnited States
-
Janssen Research & Development, LLCWithdrawnRelapsed/ Refractory Multiple MyelomaUnited States, Poland
-
Allogene TherapeuticsActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Kathleen DorritieBristol-Myers SquibbRecruitingRelapsed and Refractory Multiple MyelomaUnited States
-
MiNK TherapeuticsCompletedRelapsed/Refractory Multiple MyelomaUnited States
-
AmgenCompletedRefractory Multiple Myeloma | Relapsed Multiple MyelomaCanada, Belgium, Spain, United States, Korea, Republic of, Australia, Czechia, Taiwan, Hungary, Austria, Romania, Japan, United Kingdom, Greece, Turkey, Bulgaria, France, Russian Federation, Poland
-
Altor BioScienceNational Cancer Institute (NCI)TerminatedRelapsed or Refractory Multiple MyelomaUnited States
-
Washington University School of MedicineGenzyme, a Sanofi CompanyCompletedRelapsed Or Refractory Multiple MyelomaUnited States
-
Indapta Therapeutics, INC.RecruitingMultiple Myeloma | Refractory Multiple Myeloma | Refractory Non-Hodgkin Lymphoma | NHL | Blood Cancer | Relapsed Multiple Myeloma | Relapsed Non-Hodgkin LymphomaUnited States
-
Gracell Biopharmaceuticals, Inc.RecruitingRelapsed/ Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
Multiple Myeloma Research ConsortiumEli Lilly and Company; GlaxoSmithKline; AbbVie; Takeda; Genentech, Inc.; Celgene Corporation and other collaboratorsRecruitingRelapsed Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
Precision BioSciences, Inc.TerminatedRelapsed/Refractory Multiple MyelomaUnited States
-
Kite, A Gilead CompanyArcellx, Inc.RecruitingRelapsed and Refractory Multiple MyelomaUnited States
-
Elvira UmyarovaSanofiRecruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
University of WashingtonGenzyme, a Sanofi CompanyRecruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Abdullah KhanRecruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Mayo ClinicRecruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
University of MiamiKaryopharm Therapeutics IncRecruitingRelapsed and Refractory Multiple MyelomaUnited States
-
Oncopeptides ABTerminatedRelapsed and/or Relapsed-refractory Multiple MyelomaUnited States, Netherlands, Denmark, Sweden, Italy
-
Memorial Sloan Kettering Cancer CenterBristol-Myers SquibbTerminatedRelapsed/Refractory Multiple MyelomaUnited States
-
NexImmune Inc.SuspendedRelapsed Refractory Multiple MyelomaUnited States